Mark Stenhouse
Director/Board Member bij PHATHOM PHARMACEUTICALS, INC.
Vermogen: 95 580 $ op 31-03-2024
Profiel
Mark Stenhouse is an Independent Director at Phathom Pharmaceuticals, Inc. He previously worked as a Director at Prometheus Laboratories, Inc. from 2018 to 2020.
Mark also served as the Vice President-US Immunology at Abbott Laboratories from 2006 to 2010 and as the General Manager-Screening at EXACT Sciences Corp.
from 2019 to 2021.
Prior to that, he held the position of Vice President-U.S.
Immunology at AbbVie, Inc. from 2016 to 2018.
Mark's current job includes being the Chief Operating Officer at Prometheus Biosciences, Inc. from 2021 to 2023.
He completed his undergraduate degree at the College of Charleston.
Bekende belangen in openbare bedrijven
| Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
|---|---|---|---|---|
| 25-05-2023 | 9 000 ( 0.02% ) | 95 580 $ | 31-03-2024 |
Actieve functies van Mark Stenhouse
| Bedrijven | Functie | Begin |
|---|---|---|
| PHATHOM PHARMACEUTICALS, INC. | Director/Board Member | 17-03-2020 |
Eerdere bekende functies van Mark Stenhouse
| Bedrijven | Functie | Einde |
|---|---|---|
| PROMETHEUS BIOSCIENCES, INC. | Chief Operating Officer | 16-06-2023 |
| EXACT SCIENCES CORPORATION | Corporate Officer/Principal | 01-01-2021 |
Prometheus Laboratories, Inc.
 Prometheus Laboratories, Inc. Pharmaceuticals: MajorHealth Technology Prometheus Laboratories, Inc. develops and commercializes novel pharmaceutical and diagnostic products. Its enables physicians to provide individualized patient care. It applies the principles of personalized medicine to the diagnosis and treatment of gastrointestinal diseases and applies it to oncology. The firms markets and promotes pharmaceutical products and complementary proprietary diagnostic testing services. The company was founded by Jonathan Braun, Stephan R. Targan, Michael J. Walsh, and Scott L. Glenn in 1995 and is headquartered in San Diego, CA. | Director/Board Member | 01-10-2020 |
| ABBVIE INC. | Corporate Officer/Principal | 01-03-2018 |
| ABBOTT LABORATORIES | Corporate Officer/Principal | 01-03-2010 |
Opleiding van Mark Stenhouse
| College of Charleston | Undergraduate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Beursgenoteerde bedrijven | 3 |
|---|---|
| ABBOTT LABORATORIES | Health Technology |
| EXACT SCIENCES CORPORATION | Health Technology |
| ABBVIE INC. | Health Technology |
| Bedrijven in privébezit | 3 |
|---|---|
Prometheus Laboratories, Inc.
Prometheus Laboratories, Inc. Pharmaceuticals: MajorHealth Technology Prometheus Laboratories, Inc. develops and commercializes novel pharmaceutical and diagnostic products. Its enables physicians to provide individualized patient care. It applies the principles of personalized medicine to the diagnosis and treatment of gastrointestinal diseases and applies it to oncology. The firms markets and promotes pharmaceutical products and complementary proprietary diagnostic testing services. The company was founded by Jonathan Braun, Stephan R. Targan, Michael J. Walsh, and Scott L. Glenn in 1995 and is headquartered in San Diego, CA. | Health Technology |
Prometheus Biosciences, Inc.
 Prometheus Biosciences, Inc. BiotechnologyHealth Technology Prometheus Biosciences, Inc. engages in operation of a biopharmaceutical company. It focuses on the discovery, development, and commercialization of novel precision therapeutics and companion diagnostics for patients living with unmet needs in gastroenterology and autoimmune diseases. The company was founded by Scott Glenn and Stephan Targan on October 26, 2016 and is headquartered in San Diego, CA . | Health Technology |
| Phathom Pharmaceuticals, Inc. |
